Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01064076 · ClinicalTrials.gov registry record · NA
S-ICD® System IDE Clinical Study
A NA study of Tachycardia, Ventricular, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 330
- Enrollment target
- 20
- Study locations
NCT01064076 is a NA study of Tachycardia, Ventricular that has completed, run by Boston Scientific Corporation. The registered enrollment target is 330 participants, above the 219-participant average among 4 other Tachycardia, Ventricular trials with a reported enrollment target (51% higher). The trial reports 20 study locations across 10 states.
The verdict
NCT01064076, a NA study of Tachycardia, Ventricular, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 330 participants
- Enrollment target
- 20
- Study locations
Study Summary
This clinical study is designed to evaluate the safety and effectiveness of the subcutaneous implantable defibrillator (S-ICD) System.
Conditions Studied
Interventions
- DEVICE S-ICD System
Study Locations (20)
California
- University of Southern California - Los Angeles
- Foothill Cardiology - Pasadena
- CMCA / Sequoia Hospital - Redwood City
- Sharp Grossmont Hospital - San Diego
- Sharp Memorial Hospital - San Diego
- Pacific Heart Institute - Santa Monica
- South Bay Electrophysiology - Torrance
Illinois
- Northwestern University - Chicago
- University of Chicago - Chicago
- Midwest Heart Foundation - Oakbrook Terrace
North Carolina
- Mid Carolina Cardiology Research - Charlotte
- Forsyth Medical Center - Winston-Salem
Ohio
- Cleveland Clinic Foundation - Cleveland
- The Ohio State University - Columbus
Arizona
- Arizona Arrhythmia Consultants - Scottsdale
District of Columbia
- Washington Hospital Center - Washington D.C.
Georgia
- Emory University School of Medicine - Atlanta
Indiana
- Parkview Research Center - Fort Wayne
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 330 participants |
| Start Date | 2010-01 |
| Est. Completion | 2013-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01064076
The ClinicalTrials.gov registry entry for NCT01064076 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 330 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 219-participant average among 4 other Tachycardia, Ventricular trials with a reported enrollment target (51% higher). The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tachycardia, Ventricular appearing as the primary indexed condition, and to 1 intervention - of which S-ICD System is the first listed.
NCT01064076 reports 20 study locations spanning 10 distinct geographic areas - top geographies include California, Illinois, North Carolina.
Frequently Asked Questions
What is clinical trial NCT01064076 about?
NCT01064076 is a clinical study titled "S-ICD® System IDE Clinical Study". This clinical study is designed to evaluate the safety and effectiveness of the subcutaneous implantable defibrillator (S-ICD) System.
What is the current status of trial NCT01064076?
This trial is currently completed. It is a NA study. The enrollment target is 330 participants. The study started on 2010-01. Estimated completion is 2013-01.
What conditions does trial NCT01064076 study?
This clinical trial studies the following conditions: Tachycardia, Ventricular.
What interventions are being tested in trial NCT01064076?
The interventions under investigation include: S-ICD System (DEVICE).
Who is sponsoring clinical trial NCT01064076?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01064076 being conducted?
This trial has 20 study locations across Arizona, California, District of Columbia, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tachycardia, Ventricular
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT)
RECRUITING · NA
-
Effectiveness of the EMPOWER™ Modular Pacing System and EMBLEM™ Subcutaneous ICD to Communicate Antitachycardia Pacing
ACTIVE NOT RECRUITING · NA
-
CyberHeart's Cardiac Arrhythmia Ablation Treatment: Patients With Refractory Ventricular Tachycardia/Fibrillation
COMPLETED · NA
-
Automatic External Defibrillation Monitoring in Cardiac Arrest
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.